Feature Image

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Announces Release of Full-Spectrum 5,000 mg Liquid CBD Hemp Oil

Posted on

SAN DIEGO, Oct. 2, 2018 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brasil has released a new full-spectrum 5,000 mg cannabidiol (CBD) hemp oil liquid for the rapidly-expanding Brazil market.

“We are very excited to announce this new CBD hemp oil product in Brazil,” said Medical Marijuana, Inc. Chief Executive Officer Dr. Stuart Titus. “The company is proud to be the first-ever to receive a permit to import CBD hemp oil products into Brazil and we will continue to stay relevant in the country by creating products that fit the needs of our Brazilian consumers.”

This new 5000 mg product was developed to meet the new specifications of Brazilian doctors who plan to recommend the product to their patients. HempMeds® Brasil was the first company to receive an import permit for CBD in Brazil and, after a series of historic rulings, Brazilian Health Regulatory Agency ANVISA removed CBD from Brazil’s prohibited substance use list, removed the substance’s import tax and is now actively subsidizing the cost of CBD for those who need financial assistance.

“Our Company is thrilled that the Brazilian government has been willing to work with us to ensure our products can get into the hands of those who need them most,” said HempMeds® Brasil Vice President Caroline Heinz. “It’s incredible to see the public’s response to our products and the rate at which the popularity of CBD hemp oil has spread here in Brazil.”

To learn more about HempMeds® Brasil, please visit https://hempmeds.com.br/.

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.

About HempMeds® Brasil

HempMeds® Brasil was the first company to receive approval from the National Sanitary Surveillance Agency (ANVISA) to import a product based on cannabidiol, a substance derived from hemp, a plant of the genus Cannabis. Currently, it is authorized to supply its products, which help in the control of diseases such as epilepsy, Parkinson’s, chronic pain and multiple sclerosis, under medical prescription. For these indications, the products can be subsidized by the Brazilian government. HempMeds® Brasil works on additional approvals for other indications. www.hempmeds.com.br.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

LEGAL DISCLOSURE

Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

CONTACT:

Public Relations Contact:

Andrew Hard

Chief Executive Officer CMW Media

P. 858-264-6600

[email protected]

www.cmwmedia.com